SAB Biotherapeutics, Inc. (SABS): SCHEDULE 13G filed Aug 12, 2026

Form type

SCHEDULE 13G

Filing date

Aug 12, 2026

Accession number

0000919574-26-004984

Filer

SAB Biotherapeutics, Inc. (CIK 1833214)